Yabosi injection on April 14, 2003

Yabosi injection on April 14, 2003

This preparation is a combination of ornithine and aspartic acid, promoting liver cell repair and reducing blood ammonia levels. Ornithine → aspartic acid → acetylglutamine → combines with blood ammonia to form urea. This product is a third-generation ammonia-reducing drug following glutamic acid, arginine, and acetylglutamine. In addition to lowering ammonia, it can also reduce enzymes and jaundice, thereby protecting the liver. Each vial contains 10 mL; for hepatic encephalopathy, administer 4–8 vials daily; for those without hepatic encephalopathy, 1–2 vials daily, with a maximum daily dose of no more than 20 vials.